
Revvity, Inc.
RVTYRevvity, Inc. (RVTY) is a global provider of laboratory testing, diagnostic products, and healthcare solutions. The company focuses on advancing scientific research and medical diagnostics through innovative technologies and comprehensive testing services, supporting healthcare providers and research institutions worldwide.
Dividend History
Investors can expect a dividend payout of $0.07 per share, scheduled to be distributed in 20 days on August 7, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 7, 2026 | $0.07 | 2026-07-17 | 2026-07-17 |
| May 8, 2026 | $0.07 | 2026-04-17 | 2026-04-17 |
| February 6, 2026 | $0.07 | 2026-01-16 | 2026-01-16 |
| November 7, 2025 | $0.07 | 2025-10-17 | 2025-10-17 |
| August 8, 2025 | $0.07 | 2025-07-18 | 2025-07-18 |
Dividends Summary
- Consistent Payer: Revvity, Inc. has rewarded shareholders with 91 dividend payments over the past 22 years.
- Total Returned Value: Investors who held RVTY shares during this period received a total of $6.37 per share in dividend income.
- Latest Payout: The most recent dividend of $0.07/share was paid 71 days ago, on May 8, 2026.
- Yield & Schedule: RVTY currently pays dividends quarterly with an annual yield of 0.25%.
- Dividend Growth: Since 2004, the dividend payout has grown by 0.0%, from $0.07 to $0.07.
- Dividend Reliability: RVTY has maintained or increased its dividend for 91 consecutive payments.
Company News
The global laboratory equipment services market is projected to grow from USD 28.94 billion in 2025 to USD 62.83 billion by 2035, at a CAGR of 8%. Growth is driven by increased R&D investments in life sciences, stricter regulatory compliance requirements, expansion of biopharma facilities, and adoption of IoT-enhanced predictive maintenance techn...
The global cord blood banking services market is projected to grow from USD 33.85 billion in 2025 to USD 49.85 billion by 2031, with a CAGR of 6.84%. Growth is driven by increasing awareness of stem cell therapies, advancements in regenerative medicine, and expanding clinical applications in treating hematological and genetic disorders. North Ame...
Carterra Inc. announced the launch of the Carterra Vega, an industry-first 48-channel High-Throughput Surface Plasmon Resonance (HT-SPR) platform that delivers 12-fold higher throughput than competing systems. The platform enables primary screening of large molecular libraries with high-resolution binding data, capable of screening over 20,000 sm...
U.S. stock futures declined on Tuesday ahead of December CPI data release. Major indices were trading lower with the S&P 500 down 0.12% and Nasdaq 100 down 0.19%. Key stocks in focus include Alphabet reaching $4 trillion market value, JPMorgan preparing to report Q4 earnings, Five9 expanding its Google Cloud partnership, and Revvity rising 4.92% ...
Wall Street extended its record-setting streak with major indices hitting all-time highs after a breakthrough in US-China trade negotiations. Trade tensions eased with potential tariff threats averted and promising discussions between diplomatic representatives.









